@article {MacWilliams2020.10.26.20217232, author = {Bruce A. MacWilliams and Sarada Prasad and Amy L. Shuckra and Michael H. Schwartz}, title = {Causal factors affecting gross motor function in children diagnosed with cerebral palsy}, elocation-id = {2020.10.26.20217232}, year = {2020}, doi = {10.1101/2020.10.26.20217232}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Cerebral palsy (CP) is a complex neuromuscular condition which may negatively impact gross motor function. Children diagnosed with CP often exhibit spasticity, weakness, reduced motor control, contracture, and bony malalignment. Despite many previous association studies, the causal impact of these impairments on motor function is unknown. In this study, we propose a causal model for motor function as measured by the 66-item Gross Motor Function Measure (GMFM-66), and estimate the direct and total effect sizes of these common impairments using linear regression based on covariate adjustment sets implied by the causal model. We evaluated 300/314 consecutive subjects with cerebral palsy who underwent routine clinical gait analysis. The largest effect sizes, as measured by standardized regression coefficients (standard error), were for static motor control (direct = 0.35 (0.04), total = = 0.40 (0.04)) and dynamic motor control (direct = 0.26 (0.04), total = 0.31 (0.04)), followed by strength (direct = 0.23 (0.04), total = 0.26 (0.04)). The next largest effect was found for gait deviations (direct = total = 0.15 (0.04)). In contrast, common treatment targets, such as spasticity (direct = 0.05 (0.03), total = 0.08 (0.03)) and orthopedic deformity (direct = 0.00 (0.03) to 0.08 (0.03), total = -0.01 (0.03) to 0.11 (0.03)), had relatively small effects. We also show that effect sizes estimated from bivariate models, which fail to appropriately adjust for other causal factors dramatically overestimate the total effect of spasticity (510\%), strength (271\%), and orthopedic deformity (192\% to -2017\%). Understanding the relative influences of impairments on gross motor function will allow clinicians to direct treatments at those impairments with the greatest influence on gross motor function and provide realistic expectations of the anticipated functional changes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialRetrospective analysisFunding StatementUnfunded study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Western IRB, Study Approved October, 2018; Renewed October 2019. Sponsor: Shriners Hospitals for Children Institution Tracking Number: SLC1810R Study Number: 1249365 IRB Tracking Number: 20182835All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur institution does not allow us to share data due to privacy concerns.}, URL = {https://www.medrxiv.org/content/early/2020/10/28/2020.10.26.20217232}, eprint = {https://www.medrxiv.org/content/early/2020/10/28/2020.10.26.20217232.full.pdf}, journal = {medRxiv} }